Identification and molecular docking study of novel angiotensin-converting enzyme inhibitory peptides from Salmo salar using in silico methods

Journal of the Science of Food and Agriculture

Volumn 98, Issue 10, 2018, Pages 3907-3914

  Yu, Zhipeng ^a,b   Chen, Yang ^a   Zhao, Wenzhu ^a   Li, Jianrong ^a   Liu, Jingbo ^c   Chen, Feng ^b,d  

^a BOHAI UNIVERSITY   (China)

^b BEIJING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

^d CLEMSON UNIVERSITY   (United States)

Author keywords

ACE inhibitory peptides; collagen; in silico; molecular docking

Indexed keywords

COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH PROTEIN; PEPTIDE;

ANIMAL; CHEMISTRY; COMPUTER SIMULATION; ISOLATION AND PURIFICATION; MOLECULAR DOCKING; SALMO SALAR;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; COLLAGEN; COMPUTER SIMULATION; FISH PROTEINS; MOLECULAR DOCKING SIMULATION; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; SALMO SALAR;

EID: 85043460552     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.8908     Document Type: Article

References (36)

1. Naish J, Medical Sciences (2nd edn). Saunders, New York (2014).
2. Lackland DT and Weber MA, Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol 31:569–571 (2015).
3. Mendis S, Puska P and Norrving B, Global atlas on cardiovascular disease prevention and control. World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, Geneva (2017).
4. George AJ, Thomas WG and Hannan RD, The renin–angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 10:745–759 (2010).
5. Ngo D, Vo T, Ryu and Kim S, Angiotensin-I-converting enzyme (ACE) inhibitory peptides from Pacific cod skin gelatin using ultrafiltration membranes. Process Biochem 51:1622–1628 (2016).
6. Gu Y and Wu J, Bovine lactoferrin-derived ACE inhibitory tripeptide LRP also shows antioxidative and anti-inflammatory activities in endothelial cells. J Funct Foods 25:375–384 (2016).
7. FitzGerald, RJ and Meisel H, Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 84:S33–S37 (2000).
8. Papadimitriou CG, Vafopoulou-Mastrojiannaki A, Silva SV, Gomes AM, Malcata FX and Alichanidis E, Identification of peptides in traditional and probiotic sheep milk yoghurt with angiotensin I-converting enzyme (ACE)-inhibitory activity. Food Chem 105:647–656 (2001).
9. Rho SJ, Lee JS, Chung YI, Kim YW and Lee HG, Purification and identification of an angiotensin I-converting enzyme inhibitory peptide from fermented soybean extract. Process Biochem 44:490–493 (2009).
10. Fan J, Hu X, Tan S, Zhang Y, Tatsumi E and Li L, Isolation and characterisation of a novel angiotensin I-converting enzyme-inhibitory peptide derived from douchi, a traditional Chinese fermented soybean food. J Sci Food Agric 89:603–608 (2009).
11. Rizzetti DA, Martin A, Corrales P, Fernandez F, Simoes MR, Pecanha FM et al., Egg white-derived peptides prevent cardiovascular disorders induced by mercury in rats: role of angiotensin-converting enzyme (ACE) and NADPH oxidase. Toxicol Lett 281:158–174 (2017).
12. Pozo-Bayon MA, Alcaide JM, Polo MC and Pueyo E, Angiotensin I-converting enzyme inhibitory compounds in white and red wines. Food Chem 100:43–47 (2007).
13. O'Keeffe MB, Norris R, Alashi MA, Aluko RE and FitzGerald RJ, Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity. J Funct Foods 34:77–88 (2017).
14. Neves AC, Harnedy PA, O'Keeffe MB and FitzGerald RJ, Bioactive peptides from Atlantic salmon (Salmo salar) with angiotensin converting enzyme and dipeptidyl peptidase IV inhibitory, and antioxidant activities, Food Chem 218:396–405 (2017).
15. Harnedy PA, FitzGerald RJ, Bioactive peptides from marine processing waste and shellfish: a review. J Funct Foods 4:6–24 (2012).
16. Li GH, Le GW, Shi HY and Shrestha S, Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr Res 24:469–486 (2004).
17. Tu ML and Feng LT, Sequence analysis and molecular docking of antithrombotic peptides from casein hydrolysate by trypsin digestion. J Funct Foods 32:313–323 (2017).
18. Nagai T and Suzuki N, Isolation of collagen from fish waste material: skin, bone and fins. Food Chem 68:277–281(2000).
19. Lafarga T, O'Connor P and Hayes M, In silico methods to identify meat-derived prolyl endopeptidase inhibitors. Food Chem 175:337–343 (2015).
20. Yu Z, Zhao W, Liu J, Lu J and Chen F, QIGLF, a novel angiotensin I-converting enzyme-inhibitory peptide from egg white protein. J Sci Food Agric 91:912–926 (2011).
21. Kumar R, Chaudhary K, Chauhan JS, Nagpal G, Kumar R, Sharma M et al., An in silico platform for predicting, screening and designing of antihypertensive peptides. Sci Rep UK 5:12512 (2015).
22. Wu J, Aluko RE and Nakai S, Structural requirements of angiotensin-converting enzyme inhibitory peptides: quantitative structure activity relationship modeling of peptides containing 4–10 amino acid residues. QSAR Comb Sci 25:873–880 (2006).
23. Horovitz ZP, Angiotensin converting enzyme inhibitors: mechanisms of action and clinical implications. Urban & Schwarzenberg, Munich (1981).
24. Jang A, Jo C, Kang K-S and Lee M, Antimicrobial and human cancer cell cytotoxic effect of synthetic angiotensin-converting enzyme (ACE) inhibitory peptides. Food Chem 107:327–336(2008).
25. Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Raghava GP et al., In silico approach for predicting toxicity of peptides and proteins. PLOS One 8:e73957 (2013).
26. Grosdidier A, Zoete V and Michielin O, SwissDock, a protein–small molecule docking web service based on EADock DSS. Nucleic Acids Res 39:W270–W277 (2011).
27. Matsui T, Yukiyoshi A, Doi S, Sugimoto H, Yamada H and Matsumoto K, Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J Nutr Biochem 13:80–86 (2002).
28. Nakashima Y, Arihara K, Sasaki A, Mio H, Ishikawa S and Itoh M, Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 67:434–437 (2002).
29. Lau DH, Nattel S, Kalman JM and Sanders P, Modifiable risk factors and atrial fibrillation. Circulation 136:583–596 (2017).
30. Zhou X, Yu S, Su J and Sun L, Computational study on new natural compound inhibitors of pyruvate dehydrogenase kinases. Int J Mol Sci 17:340 (2016).
31. Qiao L, Li B, Chen Y, Li L, Chen X, Wang L et al., Discovery of anti-hypertensive oligopeptides from adlay based on in silico proteolysis and virtual screening. Int J Mol Sci 17:E2099 (2016).
32. Pina AS and Roque ACA, Studies on the molecular recognition between bioactive peptides and angiotensin-I converting enzyme. J Mol Recognit 22:162–168 (2009).
33. Abdelhedi O, Nasri R and Mora L, Insilico analysis and molecular docking study of angiotensin I-converting enzyme inhibitory peptides from smooth-hound viscera protein hydrolysates fractionated by ultrafiltration. Food Chem 239:453–463 (2018).
34. Thomsen R and Christensen MH, MolDock: a new technique for high accuracy molecular docking. J Med Chem 49:3315–3321 (2006).
35. Duan YT, Yao YF, Huang W, Makawana JA, Teraiya SB, Thumar NJ et al., Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity. Bioorg Med Chem 22:2947–2954 (2014).
36. Thomsen R and Christensen MH, MolDock: a new technique for high accuracy molecular docking. J Med Chem 49:3315–3321 (2006).